Cases of Neonatal Abstinence Syndrome (NAS)

have risen 83% from 2010 to 2015

Within the scope of perinatal care for women and newborns at risk of (or impacted by) substance use, communicating with families in non-stigmatizing and health-promoting ways is vital. Consistency among perinatal providers in their practices around screening, testing, interfacing with other systems, and understanding of the implications of substance use, will ultimately support the health of both women and newborns.

Offered in partnership with Illuminate Colorado, this free, eight-week ECHO series will offer Colorado perinatal providers and support personnel in the medical setting, best practice approaches for the care of families at risk of and/or impacted by prenatal substance exposure. 

ECHO COLORADO LEARNING SERIES


PRENATAL SUBSTANCE EXPOSURE: PERINATAL CARE FOR WOMEN AND NEWBORNS 

COMMITMENT:
Eight weekly ECHO sessions held virtually

AUDIENCE:
Colorado perinatal providers and support personnel working in the medical setting (MDs/DOs, PAs, NPs, RNs, Social Workers, Care Coordinators)

 

  • ECHO SESSION 1

    Patient Communication and Screening for Substance Use

    September 25, 2018

  • ECHO SESSION 2

    SUD in Pregnant and Postpartum Women

    October 2, 2018

  • ECHO SESSION 3

    Legal Considerations

    October 9, 2018

  • ECHO SESSION 4

    Testing and Toxicology

    October 16, 2018

  • ECHO SESSION 5

    Interfacing with the Child Welfare System

    October 23, 2018

  • ECHO SESSION 6

    Implications for Breastfeeding

    October 30, 2018

  • ECHO SESSION 7

    Implications for Neonatal Care

    November 6, 2018

  • ECHO SESSION 8

    Plans for Safe Care

    November 13, 2018

Other Current and Upcoming ECHO Series
We are always expanding our ECHO series topics. Click here for email notifications of all future ECHO series as they are added.